Breaking News
Wrist-worn device can monitor blood pressure over an entire week.
LiveOne, a wrist-worn, wearable blood pressure monitor. Image courtesy of LiveMetric.
Michael Barbella, Managing Editor08.17.22
LiveMetrichas received U.S. Food and Drug Administration 510(k) clearance for andlaunched LiveOne, a nano-sensor technology for monitoring blood pressure every 10 seconds.
“LiveMetric’s wrist-worn, wearable blood pressure monitor is an amazing solution to the inconvenience of the current BP cuff and Holter monitor,” said George Bakris, M.D., professor of Medicine at the University of Chicago, and director of AHA Comprehensive Hypertension Center. “Its design provides an affordable, daily monitor which empowers users to know their blood pressurefrom anywhere and at any time. The band makes it possible to evaluate not only a static 24-hr ABPM, but also to monitor BP over an entire week. It could also aid in our continuous research to improve diagnosis of secondary causes of hypertension that have variable BP increases.”
LiveOne is a wrist-worn, cuff-free solution that provides real time measurements to improve the care and treatment of people with hypertensionand cardiovascular diseases.The non-invasive device requires no external calibration and continuously extracts the pressure waveform out of the radial artery. The LiveOne monitoring service will be available through health systems, health insurers, and self-insured employers for people with high blood pressure and cardiovascular disease.
“The LiveOne device is intended to combat the worldwide epidemic of hypertension by offering patients and providers meaningful, deeply personalized health information so action can be taken in real-time,” said Kelly Benning, vice president at LiveMetric. “With the same ease as wearing a watch, the LiveOne device will change how hypertension and cardiovascular disease are managed and treated by offering people a thorough understanding of how their lifestyle, behavior, and medication impact their blood pressure. We are focused on bringing this to millions of users across the channels of our customer-base.”
A change to more than a century of monitoring blood pressure using cuffs, LiveMetric provides an urgently needed monitoring system to better evaluate and monitor people from anywhere and at any time. The LiveOne band, which can be used both day and night, provides an extensive volume of data points which enables clinicians and caregivers to easily evaluate trends and the likelihood of major events.
The LiveOne wearable is the world’s first MEMS nano-sensor-based, CE and FDA-cleared device with medical accuracy highly correlated to the arterial line. LiveOne is predicated on a unique technological approach, applying an array of high-frequency nanosensors that senses and processes actual pressure, and uses proprietary machine-learning to extract blood pressure values from the shape of the pulse waveform. Unlike the traditional cuff, it is calibration-free, making it convenient and easy to use. The LiveMetric Platform provides decision support data to both payers and caregivers to improve patient outcomes and cost efficiency.
LiveMetric develops hypertension and cardiovascular disease treatments.
'; var curr = null, n = 0; function countChars(el) { var text = el.nodeValue || el.innerHTML; iterateText: for (var i = 0; i < text.length; i++) { ++n; if (n === insertIndex) { curr = el; break iterateText; } } ; return curr } var elems = elem.contents(); iterateNodes : for (var i = 0; i < elems.length; i++) { if (elems[i].childNodes.length) { for (var c = 0; c < elems[i].childNodes.length; c++) { /*if(elems[i].childNodes[c].length && NewContent==true) { break iterateNodes; } if(breakToad==true && elems[i].childNodes[c]=='
') { NewContent=true; }*/ if (countChars(elems[i].childNodes[c])) { break iterateNodes; breakToad = true; } } } } if (!$('.contentBody437700').hasClass('addedad')) { elem.find(curr).after($articleWithAd); $('.contentBody437700').addClass('addedad'); } } googletag.cmd.push(function() { var adSize = [[1, 1], [740, 150], [740, 200], [468, 60], [468, 90], [468, 100], [468, 120], [300, 250], [468, 60]]; if (mobileMode) { var adSize = [[1, 1], [300, 90], [300, 45], [300, 37], [300, 58], [300, 38], [300, 25], [300, 27], [300, 24], [300, 47], [300, 28], [300, 50], [300, 250], [266, 195], [290, 395], [300, 100], [300, 212], [300, 250], [300, 300], [300, 400], [300, 500], [300, 600], [300, 700], [300, 768], [300, 800], [300, 150], [300, 750]]; }mainContent1437700 = googletag.defineSlot('/56119504/mpo_main-content-1', adSize, 'main-content-ad-437700-1').addService(googletag.pubads()); mainContent1437700.setTargeting("mpo", ["breaking-news"]); googletag.enableServices(); }); googletag.cmd.push(function() { googletag.display('main-content-ad-437700-1'); }); $('#main-content-ad-437700-1').append("
"); checkDoubleClickIframeLoaded('mpo', 'main-content-ad-437700-1'); });
